Brainaurora Medical Technology Ltd. Files Director List to HKEX

Reuters11-18
Brainaurora Medical Technology Ltd. Files Director List to HKEX

BrainAurora Medical Technology Limited has filed an updated list of directors and their roles to the Hong Kong Stock Exchange. The Board comprises Mr. Tan Zheng, who serves as Executive Director and Chairman of the Board, alongside Non-executive Directors Mr. Li Sirui, Ms. Li Mingqiu, and Mr. Deng Feng. The company also has three Independent Non-executive Directors: Mr. Lam Yiu Por, Dr. Duan Tao, and Mr. Tu Lei. The Board operates three committees. Mr. Tan Zheng chairs the Nomination Committee, with Ms. Li Mingqiu and all three Independent Non-executive Directors-Mr. Lam Yiu Por, Dr. Duan Tao, and Mr. Tu Lei-serving as members. Mr. Lam Yiu Por chairs the Audit Committee, joined by Dr. Duan Tao and Mr. Tu Lei as members. Mr. Tu Lei chairs the Remuneration Committee, with Mr. Lam Yiu Por and Dr. Duan Tao serving as its members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brainaurora Medical Technology Ltd. published the original content used to generate this news brief on November 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment